Arix Bioscience PLC has received a notification of major holdings from Weiss Asset Management LP, the Investment Manager to Brookdale Global Opportunity Fund and Brookdale International Partners, L.P. The notification, dated January 2, 2024, indicates that the total number of voting rights of the issuer is 129,389,508. As of the threshold crossing date, Weiss Asset Management LP holds 5.19% of voting rights through financial instruments, with 2.90% held by Brookdale International Partners, L.P. and 2.29% held by Brookdale Global Opportunity Fund.
The notification specifies that the financial instruments with similar economic effect held by Weiss Asset Management LP are in the form of CFDs (Contracts for Difference) with a cash settlement, amounting to 6,725,000 voting rights, representing 5.19% of the total voting rights. The notification also includes details of the person subject to the notification obligation, including the full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held.
Weiss Asset Management LP is the Investment Manager to Brookdale Global Opportunity Fund and Brookdale International Partners, L.P. The notification was completed in Boston, USA, on January 4, 2024. This announcement was transmitted by EQS Group, and the issuer is solely responsible for its content.
This notification provides insight into the changes in the breakdown of voting rights for Arix Bioscience PLC and the holdings of Weiss Asset Management LP, Brookdale Global Opportunity Fund, and Brookdale International Partners, L.P.